BRITISH SOCIETY FOR HAEMATOLOGY
BSH 2020 VIRTUAL9-14 November 2020 Virtual Conference
N. Poster
Poster title
Applicant name
Status
 |
|
|
|
| PO-001 | Whole genome profiling of adult B-other acute lymphoblastic leukaemia on the UKALL14 trial | Daniel Leongamornlert |  Received |
 |
|||
| EP-001 | Outcomes following treatment discontinuation in chronic myeloid leukaemia ( CML ): real-world experience from 3 regional UK centres | Farooq Wandroo | Received |
|
|||
| EP-002 | Could CD45 have a role in the development of myeloid malignancies? | Maryam Ahmed Al Barashdi | Received |
|
|||
| PO-002 | Regulation of Acute Myeloid Leukaemia Maintenance by Wilms Tumour 1 in an Isoform Specific Manner | Sandeep Potluri | Received |
|
|||
| PO-003 | BCAT1 increases sensitivity to Cytarabine and confers CXXC motif derived resistance to pro-oxidant treatment in Acute Myeloid Leukaemia cells | James Hillier | Received |
|
|||
| EP-003 | The impact of PCR thermocycling conditions, DNA template concentration and inter-operator variation on determining allelic ratio in the detection of FLT3-ITD mutations in AML. | Andy Robinson | Received |
|
|||
| PO-004 | Exploration of the variant composition in the genome of pediatric and adult recurrent acute myeloid leukemia | Svea Stratmann | Received |
|
|||
| EP-004 | Identification of a new target patient population for ibrutinib treatment. | Barbara Guinn | Received |
|
|||
| EP-005 | The clinical significance of FLT3-ITD allele burden in AML; a long-term retrospective single centre study. | Alasdair Duguid | Received |
|
|||
| EP-006 | Platelet recovery after the first cycle of DA chemotherapy for AML is an independent predictor of survival | Sandra Sookramanien | Received |
|
|||
| EP-007 | Antibody Immunotherapy treatment for adults with B - Acute Lymphoblastic Leukaemia A Real-World Analysis. | Tania Dexter | Received |
|
|||
| EP-008 | Inotuzumab ozogamicin vs. blinatumomab for adults with Philadelphia chromosome-negative relapsed/refractory B-cell acute lymphoblastic leukaemia in Scotland: corresponding cost-effectiveness and relative treatment effect. | Alexander Smith | Received |
|
|||
| PO-009 | Efficacy of FMS-like Tyrosine Kinase 3 (FLT3) Inhibitors in Patients with Acute Myeloid Leukemia | THURA HTUT | Received |
|
|||
| EP-010 | Incidence and management of PEGylated-asparaginase related thrombosis in adults with ALL | matthew poynton | Received |
|
|||
| PO-010 | Combination Therapies Targeting Apoptosis pathways in Paediatric AML | Ahlam Ali | Received |
|
|||
| PO-011 | Combination therapies targeting DNA Damage signalling as a therapeutic strategy in Acute Myeloid Leukaemia. | Laura Monaghan | Received |
|
|||
| PO-012 | Use of next generation sequencing to identify AML with germline predisposition; an essential diagnostic test | Alasdair Duguid | Received |
|
|||
| EP-012 | Relapsed Acute Lymphoblastic Leukaemia Diagnosed Using Femoral Head Histology | Jennifer Ryan | Received |
|
|||
| PO-013 | Inhibition of Myeloid Cell Leukaemia 1 (MCL1) overcomes Bromodomain and Extra-Terminal (BET) inhibition resistance in Acute Myeloid Leukaemia (AML) cells | ELENI LADIKOU | Received |
|
|||
| EP-013 | 19 courses of CPX-351 for the treatment of AML | Stephen Boyd | Received |
|
|||
| PO-014 | Analysis of Treatment Patterns and Outcomes for Patients With Therapy-related Acute Myeloid Leukaemia and Acute Myeloid Leukaemia With Myelodysplasia-related Changes Diagnosed in England Between 20112016 Using Hospital Episode Statistics | Alex Legg | Received |
|
|||
| EP-014 | The role of nutrition in aggressive haematological malignancies a single-centre review of patients receiving intensive chemotherapy | Graham McIlroy | Received |
|
|||
| PO-015 | Synergistic inhibition of FLT3-ITD Acute Myeloid Leukaemia cell growth in vitro using combination of FLT3 inhibitor quizartinib and standard chemotherapeutic agent cytarabine (also known as AraC) | Salihanur Darici | Received |
|
|||
| EP-016 | The utility of flow cytometry in the diagnosis of acute monocytic and monoblastic leukaemias | Ian Devanny | Received |
|
|||
| PO-017 | Whose choice is it anyway? A multi-national and multi-stakeholder perspective on shared treatment decision making in older adults with acute myeloid leukaemia | Lucy Morgan | Received |
|
|||
| POA-017 | Genetic and genomic characterisation of older adults with acute lymphoblastic leukemia treated on the UKALL14 and UKALL60 clinical trials | Anthony Moorman | Received |
|
|||
| EP-018 | Evaluating Vyxeos use in routine clinical practice; data from the South East Scotland Cancer Network | Victoria Campbell | Received |
|
|||
| PO-018 | Findings from the UK NEQAS for Leucocyte Immunophenotyping Haematological Malignancy Bone Marrow Aspirate Assessment programme | Alison Whitby | Received |
|
|||
| EP-019 | High Risk Cytogenetic Abnormalities in Acute Myeloid Leukemia-Single Centre Experience | Shawana Kamran | Received |
|
|||
| PO-019 | Optimising diagnosis and management of acute chest syndrome in sickle cell disease through a full cycle audit of adherence to the BSH guidelines | Jennifer Davies | Received |
|
|||
| EP-020 | Single Hospital Retrospective Review of patients in Treatment Free Remission (TFR) following therapy with Tyrosine Kinase Inhibitors (TKIs) for Chronic Myeloid Leukemia (CML) | Sumant Kundu | Received |
|
|||
| PO-020 | Graphical Description of Performance Characteristics of Laboratories and Assays using data from the UK NEQAS for Haematinics | Finlay MacKenzie | Received |
|
|||
| PO-021 | A review of bleeding events associated with anticoagulants that have led to patient harm with a primary focus on transitions of care | Devi Shantini Rata Mohan | Received |
|
|||
| EP-022 | Single Centre Experience in Use of Leukapheresis for Management of Leukostasis in High Count Leukaemia. | fenella Willis | Received |
|
|||
| EP-023 | The feasibility and impact of remote teaching for haematology registrars | Thomas Erblich | Received |
|
|||
| PO-023 | On Arterial Blood Gas: how can we reduce avoidable sampling? | Aina Pons | Received |
|
|||
| PO-024 | Guidelines and Chips: Food for thought in supporting trainees. | Asha Aggarwal | Received |
|
|||
| EP-024 | A Toolkit for Undertaking a Volunteer OOPE/visit to a Low Resource Country | Matthew Player | Received |
|
|||
| PO-025 | CDx report program - assessment of the current reporting practice for haemato-oncology companion diagnostics (CDx) markers in the UK and Ireland | Neil Atkey | Received |
|
|||
| EP-025 | A little learning is a dangerous thing how little do we know about when to treat pulmonary embolism? | Bernard Maybury | Received |
|
|||
| PO-026 | The Haematology Summit 20142019: evolution of a national medical education programme | Nigel Prynn | Received |
|
|||
| PO-027 | An audit on blood picture request forms submitted to haematology laboratory in a tertiary care hospital in Sri Lanka | Thanusha Wijegunaratne | Received |
|
|||
| PO-028 | Education and Training of Healthcare Scientists in Haematology - fit for the future? | Sheila OConnor | Received |
|
|||
| EP-029 | Cardiovascular risk factors and events in a district general haematology population undergoing cytotoxic chemotherapy | Jonathan Bennett | Received |
|
|||
| PO-029 | Knowledge, Perception and Opinion of Health Workers on Bone Marrow Transplantation in Public Sector Hospital | AISHA MAHESAR | Received |
|
|||
| PO-030 | A different kind of OOPE, volunteering to improve Haematology services in Malawi. | Matthew Player | Received |
|
|||
| EP-031 | Updated Audit of the Use of Pegylated Interferon in Patients with Myeloproliferative Neoplasms.Are Patients Maintained on Less Frequent Dosing than Once Weekly? | Catherine Loughran | Received |
|
|||
| PO-031 | Haembase: Improving the Quality of a Free Open Access Medical Education Resource Targeted at Haematologists in Training | Tom Bull | Received |
|
|||
| PO-033 | Suggestions for the monitoring and follow up of patients with systemic mastocytosis based on a single centre tertiary experience. | Matthew Alley | Received |
|
|||
| EP-034 | Autoimmune myelofibrosis associated with Sjogrens syndrome successfully treated with steroids and improved myelofibrosis | SEIJI KAKIUCHI | Received |
|
|||
| PO-034 | A study of Telomere length as a predictor for multi-system complications and outcomes in Bone marrow failure disorders | Shreyans Gandhi | Received |
|
|||
| PO-035 | The Impact of Immune Thrombocytopenia (ITP) on Activities of Daily Living: Findings reported by UK patients and physicians from the ITP World Impact Survey (I-WISh) | Tom Bailey | Received |
|
|||
| EP-036 | An audit of complications arising in central venous access devices (CVADs) in adult Haematology patients, Chesterfield Royal Hospital | Rowena Faulkner | Received |
|
|||
| PO-036 | Prolonged corticosteroid use in newly diagnosed primary immune thrombocytopenia | Kieran Burton | Received |
|
|||
| EP-037 | A case of Refractory Heparin induced thrombocytopenia | Nitha Ramachandran | Received |
|
|||
| PO-037 | Patients and Health Care Professionals Perspectives on Treatment Goals in Sickle Cell Disease A UK Perspective: Results From the International Sickle Cell World Assessment Survey (SWAY) | Tom Bailey | Received |
|
|||
| EP-039 | Investigating compliance of haematology patients with recommended pneumococcal and influenza vaccines. | Hamish Miller | Received |
|
|||
| PO-040 | Final results from the Apixaban Length-Of-Stay Pulmonary Embolism study - Hospital Admissions (ALPHA-PE) | Emma Still | Received |
|
|||
| EP-040 | Acute haemolysis in a Glucose-6-Phosphate-Dehydrogenase Deficient patient receiving high-dose Vitamin C therapy for metastatic caecal cancer: a case report | Rebecca Sen | Received |
|
|||
| EP-041 | Nucleic Acid Containing Units (NACU); A New Parameter in Haematology | Graham Gibbs | Received |
|
|||
| PO-042 | The Differential Diagnosis of Basophilia in Patients Undergoing BCR-ABL Testing | Caleb Smith | Received |
|
|||
| EP-042 | The Advent of the Extremely Elderly Clinic: Not If, But When? A District General Hospital Experience | Ruby Haji | Received |
|
|||
| PO-043 | Immunological effects of ponatinib therapy in patients with chronic myeloid leukaemia | Patrick Harrington | Received |
|
|||
| EP-043 | Pica in women in rural South Africa | Tessa Fautz | Received |
|
|||
| PO-044 | When should Haematologists see patients with asymptomatic lymphocytosis? | Peter Johnstone | Received |
|
|||
| EP-044 | ASSESSMENT OF FUNCTIONAL IRON STATUS IN PATIENTS WITH CHRONIC KIDNEY DISEASE ATTENDING UNIVERSITY OF ILORIN TEACHING HOSPITAL, ILORIN, NIGERIA . Sanni E.O , Olawumi H.O, Durotoye I.A, Olarewaju T.O, Babatunde AS, Shittu A.O, Biliaminu SA | Emmanuel Sanni | Received |
|
|||
| PO-045 | UK Adult Immune Thrombocytopenia (ITP) Pregnancy Registry: Collaborative research to better understand outcomes: the first 24 months. | Priyanka Raheja Makhija | Received |
|
|||
| EP-045 | Rhapsody Alerts - How Effective Are They? A Quality Improvement Project | Yasmin Nikookam | Received |
|
|||
| EP-046 | Review of antifungal treatment prescriptions for Haematology inpatients at Nottingham University Hospital | Rashmi Chandrashekar | Received |
|
|||
| PO-047 | Refining the erythrocytosis diagnostic pathway: an audit of current practice compared to British Society for Haematology guidelines. | Rebekah Williams | Received |
|
|||
| EP-048 | A Quantitative Approach to differentiate haemolysis from dilutional changes in patients with Malaria | Fatima Sharif | Received |
|
|||
| PO-049 | A Clinical Audit on Compliance with British Society of Haematology Guidelines for Diagnosis and Management of Philadelphia Negative Myeloproliferative Neoplasms | Farheen Karim | Received |
|
|||
| PO-050 | Disease progression in patients with essential thrombocythaemia receiving anagrelide within a single institution | Nicki Gray | Received |
|
|||
| PO-052 | Stopping IM B12: A Collaborative service development between primary and secondary care | Morag Griffin | Received |
|
|||
| PO-053 | Renal function over 10 years in patients with chronic myeloid leukaemia treated with tyrosine kinase inhibitors: A single centre experience. | Richard Hinton | Received |
|
|||
| PO-054 | Low Haemoglobin A1c (HbA1c) result: lessons learnt in clinical practice | Mai Khalifa | Received |
|
|||
| PO-055 | Efficacy and Safety of Bosutinib by Age and Modified Charlson Comorbidity Index in Previously Treated Patients With Chronic Myeloid Leukemia: Results From the Phase 4 BYOND Study | Emily Balevich | Received |
|
|||
| EP-055 | A case of Niemann-Pick disease type C diagnosed on bone marrow biopsy: A rare event | Sehreen Jahangir | Received |
|
|||
| PO-056 | Patients and Physicians Perceptions of Treatments and Goal Setting in Immune Thrombocytopenia (ITP): Findings reported by UK patients and physicians from the ITP World Impact Survey (I-WISh) | Tom Bailey | Received |
|
|||
| EP-056 | Pondering Possibilities: PRES vs PML | Amanda Swan | Received |
|
|||
| PO-058 | Ruxolitinib In Myelofibrosis: A Multicentre Analysis of Real-World Patients In England, Northern Ireland and Wales | James Russell | Received |
|
|||
| PO-059 | Abstract Steroid Induced Hyperglycemia and Diabetes on the Haematology Ward: Are we getting it right? Re-audit following Initiation of JBDS-IP Guidelines and Teaching | Katharine Lazarus | Received |
|
|||
| EP-061 | Contemporary Real-world Treatment Patterns of Chronic Lymphocytic Leukaemia (CLL) in England | Satoshi Hori | Received |
|
|||
| PO-061 | Managing Patients with Systemic Mastocytosis with Associated Haematological Neoplasm: UK Single Centre Experience | Deepti Radia | Received |
|
|||
| PO-062 | Prevalence of latent iron deficiency in early pregnancy in a tertiary care hospital in Sri Lanka | Neelakshi De Silva | Received |
|
|||
| EP-062 | Utility of FDG-PET CT-directed splenic biopsy in lymphoma diagnosis | Jawad Saeed | Received |
|
|||
| EP-063 | The GELOX-radiotherapy sandwich regime is a highly effective outpatient regimen for limited stage Extranodal NK/T cell Lymphoma nasal type with acceptable toxicity | Jawad Saeed | Received |
|
|||
| PO-063 | Physician Associate (PA) led Myeloproliferative Neoplasm (MPN) telephone clinics: is this the way forward to a revolutionised service? | Mai Khalifa | Received |
|
|||
| PO-064 | Capillary Glucose Monitoring in Haematology Inpatients on Glucocorticoids | Vinita Ruparel | Received |
|
|||
| EP-066 | Risk stratifying patients presenting with lymphadenopathy an audit of 2 week wait referrals for suspected haematological malignancy compared to NICE guidance | Matthew Cant | Received |
|
|||
| EP-067 | Vaccination Recommendation in Newly Diagnosed Chronic lymphocytic Leukaemia: A Retrospective Audit | Ruth Jones | Received |
|
|||
| EP-068 | Implementing Venetoclax treatment into Day Case setting for patients at High Risk of Tumour Lysis Syndrome; University Hospital Southampton NHS Foundation Trust experience | Klara Matulay | Received |
|
|||
| PO-068 | The diagnostic yield of bone marrow biopsy in patients with liver failure | Thinzar Ko Ko | Received |
|
|||
| EP-069 | 18Fluoromethylcholine PET/CT: a new tool for CNS lymphoma | Kirsty Marshall | Received |
|
|||
| EP-070 | Local experience of the use of IVE methotrexate chemotherapy for the treatment of systemic T cell lymphoma. | Thomas Fail | Received |
|
|||
| PO-071 | The efficacy and predictive value of primary care two-week wait referrals for suspected haematological cancer: quality evaluation of GP referrals and their outcomes. | Anmol Jaiswal | Received |
|
|||
| PO-072 | Symptom burden in Immune Thrombocytopenia (ITP): Findings reported by UK patients and physicians from the ITP World Impact Survey (I-WISh) | Tom Bailey | Received |
|
|||
| EP-072 | Impact of Liso-cel Treatment on Health-Related Quality of Life and Health Utility in Patients With Relapsed/Refractory Aggressive B-Cell Non-Hodgkin Lymphoma: TRANSCEND NHL 001 | Donald Patrick | Received |
|
|||
| PO-073 | The clinical characteristics, Diagnosis and Management of patients with Mastocytosis in a Tertiary Centre | Katie Hoyles | Received |
|
|||
| PO-074 | An evaluation of double or triple positivity in JAK2 positive Essential Thrombocythaemia and Primary Myelofibrosis | Mohammed Khan | Received |
|
|||
| EP-074 | IS THE ALL-ORAL DEVEC METRONOMIC SCHEDULE A BETTER ALTERNATIVE TO INFUSIONAL CHEMOTHERAPY PROTOCOLS IN ELDERLY WITH PERIPHERAL T-CELL LYMPHOMA? | M CHRISTINA COX | Received |
|
|||
| PO-075 | An audit of Tumour Lysis Syndrome prophylaxis in patients with haematological malignancies. | Alexis Cairns | Received |
|
|||
| PO-076 | Establishing Haematology services in low income and low resource settings Experiences from Northern Tanzania | steven leak | Received |
|
|||
| EP-077 | Anthracycline prescribing in Lymphoma: Traffic light guidance using NT-proBNP and echocardiogram | Khaing Nyunt | Received |
|
|||
| PO-077 | Retrospective analysis of full blood counts and iron studies on patients diagnosed with bowel cancer. | Toby Ball | Received |
|
|||
| EP-078 | Post discharge care needs for patients with treated Primary CNS Lymphoma a baseline single centre retrospective study | Ekram Omer | Received |
|
|||
| PO-078 | Neutropenic Sepsis: Can We Do Better? | Michael Caruana Dingli | Received |
|
|||
| POA-079 | UK Patient perceptions on the symptomatic and emotional burden of vaso-occlusive crises resulting from Sickle cell disease | Tom Bailey | Received |
|
|||
| EP-080 | Palliative care needs during inpatient stay for commercial chimeric antigen receptor T-cell infusion at the Newcastle-Upon-Tyne Hospitals NHS Foundation Trust | Katherine Smith | Received |
|
|||
| PO-081 | Updated Results of a Phase Ib/II Randomised Study: Polatuzumab Vedotin (Pola) Plus Bendamustine (B) and Rituximab (R) in Relapsed/Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL) | Megan Fox | Received |
|
|||
| EP-081 | EPIDEMIOLOGY OF HAEMATOLOGICAL MALIGNANCIES IN NATIONAL HOSPITAL ABUJA: A TEN-YEAR RETROSPECTIVE STUDY | Iniabasi Ekaete David | Received |
|
|||
| EP-082 | Experiences of providing commercial Chimeric Antigen Receptor (CAR-T) cell therapy at the Northern Centre for Cancer Care | Katherine Smith | Received |
|
|||
| EP-083 | Btk Inhibitor Ibrutinib Impairs Fcγ947;RIIa-Mediated Responses of Platelets from Healthy Donors and Chronic Lymphocytic Leukaemia Patients to Bacteria. | Leigh Naylor-Adamson | Received |
|
|||
| PO-083 | UK CLL Forum 5 year update on 315 relapsed refractory CLL patients treated with ibrutinib in 66 UK and Ireland centres | George Follows | Received |
|
|||
| EP-084 | ACOPP Chemotherapy for Frontline Treatment of Older Patients with Hodgkin Lymphoma - a Pilot Study | Matthew Wilson | Received |
|
|||
| PO-085 | Escalated BEACOPDac as first line therapy in 100 Hodgkin lymphoma patients reduces red cell transfusion requirements and may shorten time to menstrual period recovery whilst maintaining efficacy compared to escalated BEACOPP | Anna Santarsieri | Received |
|
|||
| EP-085 | Novel synthetic thienopyridine derivatives induce tubulin disruption and cell cycle arrest in malignant B cells with level of activity related to their chemical structure | Christopher Broughton | Received |
|
|||
| PO-086 | Addition of bendamustine to Brentuximab vedotin leads to improved complete metabolic remission rates in children, adolescents and young adults with relapsed and refractory classical Hodgkin lymphoma: a retrospective, single centre series | Annabel McMillan | Received |
|
|||
| EP-087 | Outcomes of patients with refractory Peripheral T-cell lymphoma, Angioimmunblastic and other nodal lymphomas of T follicular helper-cell origin (OPerA) | Waqas Jehangir | Received |
|
|||
| EP-088 | INCIDENCE OF CARDIOTOXICITY IN ANTRACYCLINE BASED CHEMOTHERAPY IN LYMPHOMA PATIENTS: A SINGLE CENTRE EXPERIENCE | charlotte bloodworth | Received |
|
|||
| PO-088 | Adoption of rapid obinutuzumab infusions: real world experience | Joel Cunningham | Received |
|
|||
| EP-089 | A single centre experience of using ciclosporin and mycophenolate mofetil immunosuppression in relapsed/refractory angio-immunoblastic T cell lymphoma. | Kanchana De Abrew | Received |
|
|||
| PO-089 | Brentuximab vedotin plus chemotherapy for Stage III/IV classical Hodgkin lymphoma: 4-year update of the ECHELON-1 study | Hedley Coppock | Received |
|
|||
| PO-090 | Structural and functional variability of the tumour B-cell receptor indicates a role for environmental influences on the behaviour of mantle cell lymphoma | David Dutton | Received |
|
|||
| EP-091 | Treatment decisions in Waldenstroms Macroglobulinaemia; outcomes from the South East Scotland Cancer Network | Alasdair Duguid | Received |
|
|||
| PO-091 | Systemic ALCL treated in routine clinical practice: survival outcomes following first-line chemotherapy from an international multicentre cohort study | Martinez-Calle Nicolas | Received |
|
|||
| PO-092 | Ibrutinib at first relapse for mantle cell lymphoma: a United Kingdom real-world analysis of outcomes in 211 patients | Rory McCulloch | Received |
|
|||
| EP-092 | Safety, efficacy and tolerability of the NORDIC regimen in the front-line treatment of transplant-eligible patients with mantle cell lymphoma | Jake Tobin | Received |
|
|||
| PO-093 | Finding the five percent: Predicting Adult T-cell Leukaemia/Lymphoma (ATLL) in Human T-cell leukaemia Virus-1 (HTLV-1) carriers using a novel flow cytometric method | Sonia Wolf | Received |
|
|||
| EP-094 | Real World Outcomes for Treatment of Diffuse Large B cell Lymphoma in Patients aged 80 and over | Rachel Cooke | Received |
|
|||
| PO-096 | Serial troponin measurement during anthracycline-containing chemotherapy may predict early cardiotoxicity that is amenable to primary prevention with ACE inhibitors | Ipek Cakmak | Received |
|
|||
| PO-097 | Successful Employment of Spatial Imaging Mass Cytometry in Follicular Lymphoma Confirms a Central Role of Follicular Helper T-Cells in Disease Pathogenesis | Elizabeth Phillips | Received |
|
|||
| PO-098 | Minimal Residual Disease and the Prediction of Survival Outcomes in Chronic Lymphocytic Leukaemia: A Pooled Analysis of Observational and Clinical Trial Data | Charlotte Johnston | Received |
|
|||
| PO-099 | Incidence of BTK mutations in chronic lymphocytic leukaemia treated with BTK inhibitors in a single UK institution | Elisa Santambrogio | Received |
|
|||
| PO-100 | Lymph node core biopsy: outcomes from 554 consecutive biopsies and prospective patient experience survey demonstrate a safe, rapid, reliable diagnostic method for lymphoma | Aoife Dervin | Received |
|
|||
| EP-100 | An Analysis of Patients Treated with Weekly Salvage Chemotherapy Regimens forHigh Grade Lymphoma | Seetha Sureshkumar | Received |
|
|||
| EP-101 | Real world experience of KPD use in relapsed or refractory myeloma. | Aisling Barrett | Received |
|
|||
| PO-102 | Modeling R-CHOP chemoimmunotherapy in murine lymphoma to characterize and overcome resistance | Bernard Maybury | Received |
|
|||
| EP-102 | Mature osteoblasts induce myeloma cell death through inhibiting the Sp1-TAK1-Pim2-prosurvival Pathway | Ariunzaya Bat-Erdene | Received |
|
|||
| PO-103 | Response to brentuximab vedotin plus CHP according to CD30 expression in the ECHELON-2 trial | Hedley Coppock | Received |
|
|||
| EP-103 | Lenalidomide with Low-Dose Dexamethasone in Newly DiagnosedTransplant-Ineligible Myeloma. Real-World Experience: Data from a SingleCentre in North Wales, United Kingdom. | Chaminda Arachchilage | Received |
|
|||
| PO-104 | IGHV Analysis Utilising the Ion GeneStudio S5 System and the Oncomine BCR IGH-LR Assay Early Access Experience | Zadie Davis | Received |
|
|||
| PO-105 | Outcomes for Patients with Diffuse Large B Cell Lymphoma in the West of Scotland in the pre-CAR-T era | Matthew Wilson | Received |
|
|||
| EP-105 | Use of imaging in the management of newly diagnosed patients with myeloma at St. Georges Hospital | Ke Xu | Received |
|
|||
| PO-106 | Phase Ib/II Trial of Polatuzumab Vedotin Plus Obinutuzumab and Lenalidomide in Patients with Relapsed/Refractory Follicular Lymphoma: Primary Analysis of the Full Efficacy Population | Megan Fox | Received |
|
|||
| EP-106 | Dynamic changes in serum complements during chemotherapy in patients with Multiple Myeloma and their correlations to disease markers | Sateesh Kumar Nagumantry | Received |
|
|||
| PO-107 | Real world, multi-centre experience of daratumumab monotherapy and response to subsequent treatments in relapsed/refractory myeloma | Jessica Taube | Received |
|
|||
| EP-107 | HaemBase Cymru (HBC): An electronic data collection platform for patients treated with haematological malignancies in Wales. | Zeyad Khalaf | Received |
|
|||
| PO-108 | Myeloma: not just bones at risk of fracture assessing the increasing demand on services | Tanya Freeman | Received |
|
|||
| PO-109 | Real world outcomes in multiple myeloma in patients aged 75 and over | David Hopkins | Received |
|
|||
| EP-109 | Lenalodamide Induced ITP in myeloma patients with response to steroid and TPO agents - A rare but important event to consider- case series from single institute from south India | Nishith Vaddeboina | Received |
|
|||
| EP-110 | A Retrospective Review of Antimicrobial Use and Risk Stratification of Patients with Multiple Myeloma Admitted Due to Suspected Infection | Suzanne Raffles | Received |
|
|||
| PO-110 | The UK Experience of Daratumumab Monotherapy in Relapsed Systemic AL Amyloidosis | Oliver Cohen | Received |
|
|||
| EP-111 | Myeloma in Northland 2016-2017: incidence, risk factors and outcome | Kevin Breen | Received |
|
|||
| EP-114 | Osteonecrosis of the jaw secondary to bisphosphonate treatment in multiple myeloma - Real world data. | Lewis Vanhinsbergh | Received |
|
|||
| PO-115 | Real world experience of tandem autologous stem cell transplant for high risk multiple myeloma at a single UK centre | Huw Richards | Received |
|
|||
| PO-118 | Impact of Change of Mobilisation Method on Adequacy of Stem Cell Collection in Multiple Myeloma Patients Single Centre Experience | Valarmathi Valarmathi | Received |
|
|||
| EP-118 | Incorrect specimen collection for investigation of cryoproteins can give mis-leading results | Rachel Wheeler | Received |
|
|||
| EP-119 | Implementing a remote monitoring clinic for patients with stage A CLL | Rebecca Bowen | Received |
|
|||
| PO-120 | A Single Centre Review of Bortezomib Home-administration in Myeloma Patients: Portsmouth Experience | Kanchana De Abrew | Received |
|
|||
| EP-120 | Audit of invasive fungal disease (IFD) in paediatric haematopoietic stem cell transplant (HSCT) recipients and compliance with a national guideline for the diagnosis, prevention and treatment of fungal infections during paediatric HSCT; the Royal Marsden | Olga Tatarinova | Received |
|
|||
| EP-121 | Predicting treatment response in paediatric chronic ITP patients | Shonnelly Novintan | Received |
|
|||
| PO-121 | End of Life Management of Patients with Myeloma at University Hospitals Birmingham | Beena Salhan | Received |
|
|||
| EP-122 | Growth velocity in children with sickle cell disease is increased or maintained whilst taking Hydroxycarbamide . | Amrana Qureshi | Received |
|
|||
| PO-123 | Prevention and management of steroid-induced hyperglycaemia in outpatient myeloma chemotherapy - a tertiary centre audit and quality improvement project. | Pietro Vassallo | Received |
|
|||
| EP-123 | Retrospective Audit of the use of Cidofovir for the treatment of Adenovirus in paediatric haematopoietic stem cell transplant (HSCT) recipients; a single centre experience of variable dosing schedules over a seven year period at the Royal Marsden Hospital | Purushotham Venkatraman Ramachandran | Received |
|
|||
| PO-124 | INSIGHT MM Study Of Routine Clinical Practice In Multiple Myeloma: Analysis Of Duration Of Therapy And Treatment Sequencing In UK Patients | Jill Powell | Received |
|
|||
| EP-124 | Hydroxycarbamide: clinically effective, but parents still delay starting. | Oyinkansola Oremakinde | Received |
|
|||
| PO-125 | Efficacy of Daratumumab Combination Regimen in Patients with Multiple Myeloma: A Combined Analysis of Six Phase III Randomised Controlled Trials | THURA HTUT | Received |
|
|||
| EP-125 | Help me Grow A Quality Improvement Project on Neonatal Blood Transfusion | Ai Ling Tan | Received |
|
|||
| PO-126 | A Narrative Inquiry into Patients Experience of Receiving Blood Transfusions in a Day Unit Setting whilst in a Palliative Stage of a Haematological Malignancy. | Laraine Lloyd | Received |
|
|||
| EP-126 | Impact of changing from co-trimoxazole to alternative pneumocystis pneumonia prophylaxis on the intensity of maintenance chemotherapy in the treatment of children with Acute Lymphoblastic Leukaemia | Susan Baird | Received |
|
|||
| PO-127 | Improving Haematology Clinics: Chesterfield Royal Hospital experience | Rowena Faukner | Received |
|
|||
| EP-127 | Management of Life-Threatening Haemolytic Anaemia in an Adolescent Jehovahs Witness | Rosina Shujaat | Received |
|
|||
| PO-128 | A survey on relevance of blood test before Bortezomib in Myeloma patients in Leicester Royal Infirmary | Jennifer Tam | Received |
|
|||
| PO-129 | Pilot Initiative on Buddy Scheme in Chesterfield Royal Hospital | Jennifer Tam | Received |
|
|||
| EP-129 | Anaemia and its correlates in HAART-Nave patients in Port Harcourt, Nigeria | Hannah Omunakwe | Received |
|
|||
| EP-130 | Sickle Cell Disease Pain Management in the Emergency Department: a single centre experience | Jonathan Massie | Received |
|
|||
| PO-130 | Optimising services by offering care closer to home: The introduction of telephone consultations for patients on treatment for liver Graft vs Host Disease | Laura Ricketts | Received |
|
|||
| EP-131 | An Investigation into the presence of complement factors on erythrocyte vesicles in sickle cell disease | Chidinma Obieze | Received |
|
|||
| PO-131 | Rolling out adult and paediatric, patient centred Emicizumab education, counselling and administration training: Experience from a Haemophilia commissioned network covering a large catchment area | Udaya Reddy | Received |
|
|||
| PO-132 | Implementing a Venetoclax nursing care plan for a safe administration in a Haematology setting. | Rebecca Bowen | Received |
|
|||
| EP-133 | Characteristics of menstruation in sickle cell disease patients attending a tertiary health care centre in Northern Nigeria | Aisha Abba | Received |
|
|||
| PO-133 | Becoming a nurse Principal Investigator | Emma Williams | Received |
|
|||
| PO-134 | An eight week pilot of a weekly Haematology Day Unit Information Evening event | charlotte bloodworth | Received |
|
|||
| EP-135 | FREQUENCY OF ANEMIA AND CAUSES IN POST LIVER TRANSPLANT PATIENTS FROM TERTIARY CARE HOSPITAL IN PAKISTAN: A RETROSPECTIVE AUDIT | Samreen Khan | Received |
|
|||
| PO-135 | Nurse Led DVT service over the last 17 years: IVDU (intravenous drug users) comparison to general population | Huw Rowswell | Received |
|
|||
| PO-136 | Capillary blood sampling for anti-Xa monitoring in paediatric patients- A practice changing quality improvement project at Birmingham Childrens Hospital | Claire Horgan | Received |
|
|||
| EP-136 | Evaluation Of High Performance Liquid Chromatography Pattern And Prevalence Of Thalassemia Trait In Port Harcourt, Nigeria | Hannah Omunakwe | Received |
|
|||
| PO-137 | Significant levels of endogenous formaldehyde in humans a potential driver of Fanconi anaemia? | Luke Glover | Received |
|
|||
| EP-138 | The Successful use of Eculizumab to Switch off Haemolysis in Aggressive warm IgM Autoimmune Haemolytic Anaemia: Case Report and Literature Review | Mohammed Altohami | Received |
|
|||
| PO-138 | Intensive Care Admissions For Children With Acute Lymphoblastic Leukaemia: A 13 year single centre experience | Melpomeni Rompola | Received |
|
|||
| PO-139 | TRANSCRANIAL DOPPLER SCREENING PROGRAMME IN CHILDREN AND ADOLESCENTS WITH SICKLE CELL DISEASE: EXPERIENCE IN A DISTRICT GENERAL HOSPITAL IN THE UK. | Amrana Qureshi | Received |
|
|||
| EP-139 | Discrepant interpretation of HIT screening results on the same sample - data from a UK NEQAS for Blood Coagulation exercise. | Ian Jennings | Received |
|
|||
| EP-140 | Pre - analytical variables in haemostasis: Results of the UK National External Quality Assessment Scheme for Blood Coagulation haemolysis supplementary exercise. | Lilia Brown | Received |
|
|||
| EP-141 | Effects of Rivaroxaban on thrombophilia screening tests results from a UK NEQAS (Blood Coagulation) Exercise | Ian Jennings | Received |
|
|||
| EP-142 | Management of pregnancy-associated acquired haemophilia A: a case-series from the Oxford Haemophilia and Thrombosis Centre, UK | Ayesha Ejaz | Received |
|
|||
| PO-143 | Effects of luspatercept on iron overload and impact on responders to luspatercept: results from the BELIEVE trial | Jennifer Mark | Received |
|
|||
| PO-145 | One-Year Efficacy of Ravulizumab (ALXN1210) in Adult Patients with Paroxysmal Nocturnal Haemoglobinuria Naive to Complement Inhibitors | nira dass | Received |
|
|||
| PO-146 | One-Year Efficacy and Safety from a Phase 3 Trial of Ravulizumab in Adult Patients with Paroxysmal Nocturnal Haemoglobinuria Receiving Prior Eculizumab Treatment | nira dass | Received |
|
|||
| PO-147 | Assessment of longer-term efficacy, safety, and haematological improvement in the phase 3, randomised, double-blind, placebo-controlled MEDALIST trial of luspatercept to treat anaemia in patients with lower-risk myelodysplastic syndromes with ring sideroblasts who require red blood cell transfusions | Jennifer Mark | Received |
|
|||
| PO-148 | Evaluating luspatercept responders in the phase 3, randomised, double-blind, placebo-controlled BELIEVE trial of luspatercept in adult beta-thalassaemia patients who require regular red blood cell transfusions | Jennifer Mark | Received |
|
|||
| EP-148 | A Systematic Review and Meta- Analysis of Randomized Controlled Trials on Primary Ambulatory Thromboprophylaxis (PATP) in Patients with Ovarian Cancer Receiving Chemotherapy | THURA HTUT | Received |
|
|||
| EP-149 | Outpatient Management of Pulmonary Embolism over Ten Years in a large teaching hospital: Safe and Evolving practice. | Huw Rowswell | Received |
|
|||
| PO-149 | Unilateral Versus Bilateral Peripheral Access Using Ultrasound Machine Guidance in Patients Undergoing Red Blood Cell Exchange Transfusion: A Comparative Results | Romeo Valeza | Received |
|
|||
| PO-150 | Breakthrough Haemolysis in Adult Patients with Paroxysmal Nocturnal Haemoglobinuria Treated with Ravulizumab: Results of a 52-Week Extension from Two Phase 3 Studies. | nira dass | Received |
|
|||
| PO-151 | Patient Preferences for the Treatment of Paroxysmal Nocturnal Hemoglobinuria: Results of a Patient Survey of Ravulizumab (ALXN1210) and Eculizumab in the UK | nira dass | Received |
|
|||
| EP-151 | Clinical Characteristics and Outcomes in Patients Treated with Eculizumab for Suspected Atypical Haemolytic Uraemic Syndrome (aHUS) - A Single Tertiary Centre Experience | Matthew Alley | Received |
|
|||
| EP-152 | Do patients taking Direct Oral Anticoagulants (DOAC) require regular systematic review? Evidence from a Comprehensive Anticoagulation and Thrombosis Centre | Nausheen Kamran | Received |
|
|||
| EP-153 | Venous Thromboembolism in a large teaching hospital over the last 10 years: changing patterns of disease | Huw Rowswell | Received |
|
|||
| PO-153 | Association Between Protein C, Protein S and Cerebral Blood Flow Velocity in Sickle Cell Disease Patients with High Risk of Cerebrovascular Accident | Ebele Uche | Received |
|
|||
| EP-154 | Utility of Pro C Global assay and Factor VIII activity as anti-coagulant and pro-coagulant factors in Hepatitis C cirrhotic patients | Ahmed Almenshawy | Received |
|
|||
| EP-155 | Patients with acute Thrombotic Thrombocytopenic Purpura (TTP) should be managed in a Critical Care Setting A Single TTP Referral Centre Experience | Rebecca Jane Shaw | Received |
|
|||
| EP-156 | Why do we use warfarin today? A retrospective study from a large comprehensive anticoagulation centre. | Kumari Perera | Received |
|
|||
| PO-156 | Haemoglobin Distribution Width is Low in Alcoholic Liver Disease | Graham Gibbs | Received |
|
|||
| EP-158 | Clinical Outcomes from Lupus Anticoagulant Testing | Sarrah Tayabali | Received |
|
|||
| EP-159 | ISTH SSC plasma standard lot 5 results in a UK National External Quality Assessment Scheme for Blood Coagulation exercise | Ian Jennings | Received |
|
|||
| PO-159 | Improving the Laboratory Diagnosis of Pyruvate Kinase Deficiency | Claire Laas | Received |
|
|||
| PO-160 | Luspatercept significantly reduces red blood cell transfusion burden, regardless of gene mutation frequency, spectrum, and prognostic significance, among patients with lower-risk myelodysplastic syndromes enrolled in the MEDALIST trial | Jennifer Mark | Received |
|
|||
| EP-161 | Fixed dose prothrombin complex concentrate for direct oral anticoagulant and warfarin reversal: a rapid and effective solution | Jennifer Davies | Received |
|
|||
| PO-161 | Bone And Joint Health Markers In Persons With Haemophilia A (PwHA) Treated With Emicizumab In HAVEN 3 | Anna Kiialainen | Received |
|
|||
| EP-164 | Patients with below knee DVT are at risk of both under and over- treatment: results from a retrospective review of cases identified at University Hospitals Bristol | Sarah Westbury | Received |
|
|||
| PO-164 | Platelet storage pool disease with excessive bleeding associated with a novel FLI1 variant. | PATRICIA BIGNELL | Received |
|
|||
| PO-165 | Shear flow-based assay with HUVECs shows von Willebrand Factor (VWF) strings anchored to the endothelial surface and platelet aggregation in acute immune-mediated Thrombotic Thrombocytopenic Purpura. | Chiara Vendramin | Received |
|
|||
| EP-165 | A retrospective review of suspected thrombotic thrombocytopenic purpura cases from a tertiary referral centre | Amy Knott | Received |
|
|||
| PO-166 | Investigation of von Willebrand factor polymorphisms in congenital Thrombotic Thrombocytopenic Purpura | Chiara Lupo | Received |
|
|||
| EP-166 | Approach to manage thrombotic events while on Anti coagulation | Lovina Thomas | Received |
|
|||
| EP-167 | Heparin-induced thrombocytopaenia (HIT): an audit of the diagnostic pathway at Barts Health NHS Trust | Martin Haywood | Received |
|
|||
| EP-168 | Direct Oral Anticoagulants the real story of their side effect profile | Tara Maisel | Received |
|
|||
| PO-168 | Factor VIII levels and bleeding according to factor 8 mutation in pregnant carriers of haemophilia A: a multi-centre retrospective cohort study | Annie Collins | Received |
|
|||
| EP-169 | Monitoring direct oral anticoagulant plasma concentrations experience from the Princess Royal University Hospital | Rachna Patel | Received |
|
|||
| EP-170 | Overview of Clinical characteristics of patients with TTP (Thrombotic Thrombocytopenic Purpura) in a low socio-economic population in New York: A 6-year center experience. | Preethi Ramachandran | Received |
|
|||
| PO-171 | A Systematic Review of Efficacy and Safety of Chemical Thromboprophylaxis in Renal Transplantation | Ruchika Kohli | Received |
|
|||
| EP-171 | Comparing Patient Experience and Adherence with Rivaroxaban or Warfarin (PACT); Well, you know it (warfarin) kills rats, whats it doing to me? | Dan Sly | Received |
|
|||
| EP-173 | A Retrospective Audit of Perioperative Management of Anaemia in Patients Undergoing Elective Primary Total Hip Replacement in a District General Hospital | Nitesh Rathod | Received |
|
|||
| PO-173 | UK NEQAS for Blood Coagulation D-dimer Point of care testing programme | Dianne Patricia Kitchen | Received |
|
|||
| PO-174 | Observational study of outcomes in patients with antiphospholipid syndrome anticoagulated with Rivaroxaban | THURA HTUT | Received |
|
|||
| EP-174 | Blood donation deferral pattern in a low income blood banking service | Mutiat Ogunfemi | Received |
|
|||
| PO-175 | External Quality Assurance (EQA) for the Thromboelastometry devices: UK NEQAS BC programme update | Dianne Patricia Kitchen | Received |
|
|||
| EP-175 | Awareness and attitudes towards voluntary non-remunerated blood donation in two generational groups in Trinidad and Tobago | kenneth charles | Received |
|
|||
| EP-176 | Blood loss, cell salvage, tranexamic acid and transfusion: an audit of major surgery at a tertiary hospital | Sarah Dawson | Received |
|
|||
| EP-177 | The impact of anticoagulation and perioperative blood transfusion in fragility hip fracture patients. | Michael Greenhalgh | Received |
|
|||
| PO-177 | The differential surface expression of tissue factor between monocyte subsets | Kathryn Musgrave | Received |
|
|||
| EP-178 | An audit of cell free foetal DNA (cffDNA) screen to avoid administration of anti-D immunoglobulin in RHD negative pregnant women with RHD negative foetus. | Kamala Gurung | Received |
|
|||
| EP-179 | The Consultant Clinical Scientist in Transfusion - Overview and Reflections on the Journey to FRCPath | Tom Bullock | Received |
|
|||
| PO-179 | Anticoagulation In Palliative And End Of Life Care - Results Of A Supra-Regional Audit And Literature Review | Kat Moss | Received |
|
|||
| EP-180 | Blood management in Volta Regional Hospital (VRH), Ho, Ghana: a quality improvement project | Matthew Wells | Received |
|
|||
| PO-180 | The CAVEaT multicentre audit of venous thrombosis in patients with haematolical malignancy and thrombocytopenia: preliminary results. | Stephen Booth | Received |
|
|||
| PO-181 | Dynamic and Time-To-Event Analyses Demonstrate Marked Reduction in Transfusion Requirements for Janus Kinase InhibitorNave Myelofibrosis Patients Treated with Momelotinib Compared Head to Head with Ruxolitinib | Andrew Dye | Received |
|
|||
| EP-181 | Detection of red cell antibodies in patient plasma after 3 months storage above the recommended -30C | Kara Manning | Received |
|
|||
| EP-182 | Determination of Appropriate Deferral Time for Repeat Apharesis Platelets Concentrate Donation in Abuja, Nigeria | Chi-kadibia Ukoma | Received |
|
|||
| PO-182 | Title: A simulation study of pre-hospital whole blood transfusion: what are the benefits? | Harriet Tucker | Received |
|
|||
| PO-183 | A Feasibility Study on the Provision of Extended Matched Red Cells for Transfusion Support in Chronic Haematological Diseases | Sarah Henton | Received |
|
|||
| EP-183 | Intra-operative Blood Utilization and Wastage in a Low Resource Tertiary Hospital in Northern Nigeria | Saidu Yakubu | Received |
|
|||
| EP-184 | Cross-Trust Mandatory Training in Transfusion | Charlene Furtado | Received |
|
|||
| PO-184 | Rh antibodies in patients with sickle cell disease an on-going challenge | Catherine Booth | Received |
|
|||
| PO-185 | Group O D Negative Blood Promoting the appropriate use of an essential but limited resource | Shubha Allard | Received |
|
|||
| EP-186 | How Do They Measure Bleeding? Analyzing the Triggers Applied by the Obstetric Specialists for Initiating Blood Transfusion for Postpartum Haemorrhage | Mathurange Krishnapillai | Received |
|
|||
| PO-186 | Does Early Discharge Affect Administration Of Anti-D Ig Prophylaxis | Victoria Tuckley | Received |
|
|||
| EP-187 | Evaluation of Preoperative Haemoglobin Level and Blood TransfusionPractices among Patients Attending to a Tertiary care unit in Sri Lanka -Colombo North Teaching Hospital | Pabasara Premarathne | Received |
|
|||
| EP-188 | Blood Transfusion Refusers: A Clinical Audit About Referrals and Their Outcome | Naomi Melamed | Received |
|
|||
| PO-188 | Reduction of Platelet Thresholds to Adhere with British Society of Haematology (BSH) Guidance for Tunnelled Central Line Insertion does not Increase Bleeding Complication in Haematology Patients; a Single Centre Experience | Luke Carter-Brzezinski | Received |
|
|||
| EP-189 | Does measuring ferritin in the first or third trimester, optimise diagnosis of obstetric iron deficiency anaemia, thereby leading to prompt oral iron therapy and a reduction in blood transfusions? | Andreea Neamtiu | Received |
|
|||
| PO-189 | Alloimmunisation in Sickle Cell Disease in the North Central London Haemoglobinopathy Cohort: providing a baseline for extended red cell antigen matching and targeted donor genotyping | Katrina Fordwor | Received |
|
|||
| PO-190 | Incorrect Plasma Components Transfused: When It Comes To ABO Compatibility Do We Need To Stop Only Ever Seeing Red? | Victoria Tuckley | Received |
|
|||
| EP-190 | An insight into the knowledge, attitude and practice towards blood donation among the students, health workers and general population of Hyderabad Sindh. | NAZIA HAFEEZ | Received |
|
|||
| EP-191 | An Audit of Out-of-Hours Transfusions Across Two Hospital Sites | Catherine Booth | Received |
|
|||
| PO-191 | Transfusion 2024 defining a 5-year national strategy for clinical and laboratory transfusion practice | Shubha Allard | Received |
|
|||
| PO-192 | Patient identification errors in transfusion continue to compromise patient safety | Victoria Tuckley | Received |
|
|||
| EP-192 | High Prevalence of Haemolytic Antibodies: a Challenge for Safe Blood Transfusion in Africa | Ifeyinwa Okafor | Received |
|
|||
| PO-194 | Red blood cell antibodies and adverse transfusion events in multi-transfused patients with sickle cell disease in Ghana | Lilian Antwi Boateng | Received |
|
|||
| PO-195 | Transfusion in iron deficiency anaemia: retrospective audit of the frequency and nature of transfusion in the context of iron deficiency in Scottish hospital | Sarah Beverstock | Received |
|
|||
| PO-196 | Avoidable Red cell transfusion due to Inadequate Investigation of Anaemia (ARIIA): A national study to determine if the patients that were transfused in an acute care setting were appropriately investigated for the causes of the anaemia | Alexandros Rampotas | Received |
|
|||
| EP-196 | Autologous stem cell transplantation for ed myeloma patients aged 70 years is safe and effective and similar to that of younger patients: a single centre experience | Anne Fenech | Received |
|
|||
| EP-197 | Lung function screening following allogeneic haematopoietic stem cell transplantation | Callum Wright | Received |
|
|||
| PO-197 | Impact of Fetal RHD screening upon a UK hospitals practice for Routine Antenatal Anti-D Prophylaxis (RAADP) | Anna Li | Received |
|
|||
| EP-198 | Abatacept acute graft versus host disease prophylaxis is feasible and safe when combined with post transplant cyclophosphamide in the mobilised peripheral blood haplo-identical donor setting. | Jun Yong | Received |
|
|||
| PO-198 | What Do They Know and What Should We Tell Them- Knowledge, Attitude and Education on Blood Transfusion Therapy Among Antenatal Mothers | Mathurange Krishnapillai | Received |
|
|||
| PO-199 | Five years of collaboration towards achieving total voluntary non-remunerated blood donation in Trinidad and Tobago | kenneth charles | Received |
|
|||
| EP-200 | Feasibility, safety, and efficacy of Abatacept for steroid refractory acute graft versus host disease. | Jun Yong | Received |
|
|||
| PO-200 | Audit of red cell genotyping in sickle cell disease patients in two London trusts | Yee Man Tracy Hui | Received |
|
|||
| EP-201 | The Use of Artificial Nutritional Support within a National Allogeneic Transplant Unit | Abigail Dean | Received |
|
|||
| PO-202 | Prophylactic donor lymphocyte infusion reduces the risk of relapse and increases survival in patients with mixed T cell chimerism after reduced intensity allogeneic stem cell transplantation | Richard Buka | Received |
|
|||
| EP-203 | The Treatment of Late-onset Hepatic Veno-occlusive Disease Following Hematopoietic Stem Cell Transplantation Using Defibrotide: a Case Study. | Marie Waller | Received |
|
|||
| PO-203 | Defibrotide treatment for veno-occlusive disease/sinusoidal obstruction syndrome after haematopoietic cell transplantation: outcomes by severity and multi-organ failure status in an observational registry study | Lawson Nyce | Received |
|
|||
| EP-204 | Vyxeos in high risk MDS as induction therapy prior to stem cell transplantation | Amanda Swan | Received |
|
|||
| PO-204 | Outcomes of Allografts for Acute Myeloid Leukaemia and Myelodysplastic Syndromes in Patients Aged over 60 years and over 65 years are not inferior to those of younger patients: a single centre study | Jennifer Byrne | Received |
|
|||
| PO-205 | The use of Autologous Haematopoietic Stem Cell Transplants in patients with Relapsing Remitting Multiple Sclerosis: A Meta-Analysis | Owain Greaves | Received |
|
|||
| PO-207 | First report of post-transplant autoimmune hyperlipidaemia and treatment with rituximab | Wing Yee Sin | Received |
|
|||
| PO-208 | Reduced Intensity Conditioning with Thiotepa-Fludarabine-Busulphan (TBF) and Post-Transplant Cyclophosphamide (PTC) Results in Rapid Complete Donor T-cell Chimerism in Haploidentical Recipients with Acute Myeloid Leukaemia | Rishi Banerjee | Received |
|
|||
| PO-209 | Morbidity of very long term (30 year) survivors of allogeneic haemopoietic cell transplantation 1979-1989: a single centre experience. | Nina Salooja | Received |
|
|||
BSH 2020 VIRTUAL
9-14 November 2020 Virtual Conference
Search and consult posters online
in an exclusive section
for each poster
in an exclusive section
for each poster
ACTIVE FROM 30/10/2020 TO 30/11/2021
Poster
Gallery
Gallery
Upload
Poster
Poster
Featured Poster
Vote poster
Poster Discussion
Forum
Forum
|
Digital Object Identifier. Official code used to identify documents published on internet; similar to ISBN for books. You may use this code to reference your poster in future scientific publications or CVs. It can be found from anywhere in the world. To find the poster page, log onto www.medra.org and enter the DOI, or enter in your internet browser https://dx.doi.org/ followed by the DOI string asigned to your congress.
|
|
||
|
||||
|
|
